Ardelyx (ARDX) Surges With $97.66M Revenue Beat
Ardelyx, Inc. (NASDAQ:ARDX) is a biopharmaceutical company dedicated to discovering, developing, and commercializing innovative medicines that ...
Read moreDetailsArdelyx, Inc. (NASDAQ:ARDX) is a biopharmaceutical company dedicated to discovering, developing, and commercializing innovative medicines that ...
Read moreDetails© 2022 Global Market Bulletin. All Rights Reserved.